CHINA PHARMA HOLDINGS, INC. Contracts & Agreements
40 Contracts & Agreements
- Business Finance (12 contracts)
- Business Operations (2)
- Human Resources (5)
- Real Estate (2)
- Uncategorized (19)
- Form of the Securities Purchase Agreement, dated December 12, 2024, by and between China Pharma Holdings Inc. and the Investor (Filed With SEC on December 13, 2024)
- Amendment #2 to Convertible Promissory Note dated May 23, 2024 (Filed With SEC on May 30, 2024)
- Loan Settlement Agreement between China Pharma Holdings, Inc. and Ms. Zhilin Li (Filed With SEC on April 1, 2024)
- Technology Transfer Agreement between Hainan Helpson Medical & Biotechnology Co., Ltd and Tao Liu (Filed With SEC on April 1, 2024)
- Technology Transfer Agreement between Hainan Helpson Medical & Biotechnology Co., Ltd and Lihua Li (Filed With SEC on April 1, 2024)
- Office Lease for Second Floor of the Companys Principal Executive Office Dated June 5, 2023 (Filed With SEC on April 1, 2024)
- Office Lease for Third Floor of the Companys Principal Executive Office Dated June 5, 2023 (Filed With SEC on April 1, 2024)
- Amendment to Convertible Promissory Note dated April 13, 2023 (Filed With SEC on April 20, 2023)
- Loans Extension Confirmation Letter, dated December 31, 2022, between the Company and Heung Mei Tsui confirming the extension of the loans to December 31, 2023 (Filed With SEC on March 30, 2023)
- Technology Transfer Contract, dated November 28, 2022, between Hainan Helpson Medical & Biotechnology Co., Ltd and Chengdu Bonier Medical Technology Development Co., Ltd (Filed With SEC on December 2, 2022)
- Description of Securities Registered Pursuant to Section 12 of the Exchange Act (Filed With SEC on March 30, 2022)
- Loans Extension Confirmation Letter, dated December 31, 2021, between the Company and Heung Mei Tsui confirming the extension of the loans (Filed With SEC on March 30, 2022)
- Securities Purchase Agreement between China Pharma Holdings, Inc. and Streeterville Capital, LLC dated November 17, 2021 (Filed With SEC on November 23, 2021)
- Convertible Promissory Note dated November 17, 2021 (Filed With SEC on November 23, 2021)
- Form of Incentive Stock Option Grant Agreement (Filed With SEC on September 15, 2021)
- Loans Extension Confirmation Letter, dated December 31, 2020, between the Company and Heung Mei Tsui confirming the extension of the loans (Filed With SEC on March 26, 2021)
- Loans Extension Confirmation Letter between the Company and Heung Mei Tsui confirming the extension of the loans (Filed With SEC on March 30, 2020)
- English translation of the Loan Agreement between the Company and Zhilin Li dated July 8, 2019 (Filed With SEC on August 14, 2019)
- Offer Letter dated December 12, 2018 from the Company and accepted by Ms. Zhilin Li for Ms. Li serving as a director of the Company (Filed With SEC on March 28, 2019)
- Offer Letter dated December 12, 2018 from the Company and accepted by Ms. Heung Mei Tsui for Ms. Tsui serving as a director of the Company (Filed With SEC on March 28, 2019)
- Loans Extension Confirmation Letter between the Company and Heung Mei Tsui confirming the extension of the loans (Filed With SEC on March 28, 2019)
- Loans Extension Confirmation Letter between the Company and Heung Mei Tsui confirming the extension of the loans (Filed With SEC on April 2, 2018)
- Loans Extension Confirmation Letter (Filed With SEC on March 30, 2016)
- Loans Extension Confirmation Letter (Filed With SEC on March 30, 2015)
- Loans Extension Agreement (Filed With SEC on March 20, 2014)
- Loans Extension Agreement (Filed With SEC on March 14, 2013)
- Exhibit 2.1 (Filed With SEC on January 4, 2013)
- AMENDMENT AGREEMENT TO NON-QUALIFIED STOCK OPTION AGREEMENTS OF CHINA PHARMA HOLDINGS, INC (Filed With SEC on April 30, 2012)
- FORM OF RESTRICTED SHARE AWARD AGREEMENT pursuant to the 2010 LONG-TERM INCENTIVE PLAN OF CHINA PHARMA HOLDINGS, INC. ***** (Filed With SEC on June 1, 2011)
- EMPLOYMENT AGREEMENT X(O (Filed With SEC on June 1, 2011)
- FORM OF NON-QUALIFIED STOCK OPTION AGREEMENT pursuant to the 2010 LONG-TERM INCENTIVE PLAN OF CHINA PHARMA HOLDINGS, INC ***** (Filed With SEC on June 1, 2011)
- Loan Agreement (Filed With SEC on March 3, 2011)
- CHINA PHARMA HOLDINGS, INC. WARRANT Warrant No. __ Original Issue Date: May 17, 2010 (Filed With SEC on March 3, 2011)
- Hainan Helpson Medical & Biotechnology Co., Ltd. Long-term Labor Contract (Filed With SEC on November 10, 2010)
- EMPLOYMENT AGREEMENT (Filed With SEC on August 9, 2010)
- Anhui Fuyang Xin Te Pharmaceutical Co. Ltd., Sales Contract (Filed With SEC on March 17, 2009)
- Helpson Medical & Biotechnology Co., Ltd. (Filed With SEC on March 17, 2009)
- Helpson Medical & Biotechnology Co., Ltd. (Filed With SEC on March 17, 2009)
- Raw Material Purchase / Sales Contract (Filed With SEC on March 17, 2009)
- CHINA PHARMA HOLDINGS, INC. WARRANT (Filed With SEC on March 17, 2009)
